Adam Levy
Vermögen: 55 437 $ am 30.09.2026
Vermögen: 55 437 $ am 30.09.2026
Mr. Adam S.
Levy is a Chief Financial Officer at Mineralys Therapeutics, Inc. He is on the Board of Directors at Praxis Bioresearch LLC.
Mr. Levy was previously employed as a Chief Business Officer by Vical, Inc., a Chief Business Officer by Brickell Subsidiary, Inc., a Chief Business Officer by Fresh Tracks Therapeutics, Inc., a Chief Business Officer by Miragen Therapeutics, Inc., a Senior Vice President by Merrill Lynch, Pierce, Fenner & Smith, Inc., a Vice President-Healthcare Investment Banking by Wedbush Securities, Inc., and a Chief Financial Officer by Sanifit Therapeutics SA. He received his undergraduate degree from Cornell University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.03.2026 | 2’206 ( 0% ) | 55 437 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.03.2022 |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel prodrug stimulants for treatment of chronic neuropsychiatric and neurodegenerative disorders | Direktor/Vorstandsmitglied | 19.09.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Finanzdirektor/CFO | 01.01.2022 |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Corporate Officer/Principal | 01.01.2020 |
| VIRIDIAN THERAPEUTICS, INC. | Investor Relations Kontakt | - |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.05.2016 |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Corporate Officer/Principal | 01.04.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops and manufactures prescription therapeutics products for treatment of autoimmune, inflammatory and debilitating diseases | Health Technology |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel prodrug stimulants for treatment of chronic neuropsychiatric and neurodegenerative disorders | Health Technology |
Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen